statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novel QIAcuity dPCR PanCancer Kits can detect rare mutations of EGFR and BRAF genes at the same time, while saving sample material, reducing time and cost // New QIAseq Targeted RNA-seq Panel for...

QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024

In trading on Monday, shares of Qiagen NV (QGEN) crossed below their 200 day moving average of 42.88, changing hands as low as 42.82 per share. Qiagen NV shares are currently trading down...

QGEN Makes Notable Cross Below Critical Moving Average

QIAstat-Dx Analyzer 2.0 with Software 1.6 release enables mobile access to test results, streamlining diagnostic processes and enhancing patient care // QIAstat-Dx Analyzer 2.0 also offers enhanced...

QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system

Joint educational initiative to focus on Interferon Gamma Release Assay (IGRA) benefits for healthcare providers // Updated U.S. CDC guidelines mandate IGRA testing for individuals aged 2 and older...

QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements

Venlo, the Netherlands, March 11, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited...

QIAGEN announces Form 20-F annual report filing for 2023 results

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Qiagen NV (QGEN), where a total volume of 5,610 contracts has been traded thus...

Notable Thursday Option Activity: QGEN, ZS, CHH

QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships, including gene, disease and drug causal relationships, to aid in data-driven drug discovery // AI-driven insights...

QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery

Additional ecofriendly QIAwave kits for DNA and RNA extraction receive ACT Label due to greatly improved Environmental Impact Factor compared to standard kits // QIAGEN's Sample technologies R&D lab...

QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification

Qiagen (NYSE:QGEN  Free Report)  Investment analysts at Zacks Research reduced their Q2 2024 EPS estimates for shares of Qiagen in a research report issued to clients and investors on...

Q2 2024 Earnings Forecast for Qiagen (NYSE:QGEN) Issued By Zacks Research

Morgan Stanley upgraded shares of Qiagen (NYSE:QGEN  Free Report) from an equal weight rating to an overweight rating in a research report released on Friday, Benzinga reports. The firm...

Qiagen (NYSE:QGEN) Raised to "Overweight" at Morgan Stanley

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Volume	816,213.00
52-Wk High	$49.18
52-Wk Low	$35.81

QGEN Qiagen NV

About

Feed

News

Sentiment

Earnings

Fundamentals